MedPath

Feasibility and acceptability of a specialist exercise programme for people with Parkinson's disease

Not Applicable
Completed
Conditions
Parkinson's Disease
Nervous System Diseases
Registration Number
ISRCTN11672329
Lead Sponsor
Robert Gordon University
Brief Summary

2021 Protocol article in https://pubmed.ncbi.nlm.nih.gov/34136750/ (added 18/06/2021)

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
All
Target Recruitment
31
Inclusion Criteria

Current exclusion criteria as of 05/01/2021:

1. Confirmed diagnosis of Parkinson's disease (PD)
2. Stage I-III Hoehn and Yahr Scale (appendix)
3. Mild to severe gait disturbance with a score of =2 on the Unified Parkinson’s disease Rating Scale (UPDRS) item 29
4. Able to walk independently with or without a walking aid greater than 100m
5. Stable medication for more than 3 weeks
6. Able to speak and understand English without assistance
7. Have a tablet/laptop with a webcam, that is Microsoft Teams compatible
8. Access to a stable internet connection

_____

Previous inclusion criteria:

1. Confirmed diagnosis of Parkinson's disease (PD)
2. Stage I-III Hoehn and Yahr Scale (appendix)
3. Mild to severe gait disturbance with a score of =2 on the Unified Parkinson’s disease Rating Scale (UPDRS) item 29
4. Able to walk independently with or without a walking aid greater than 100m
5. Stable medication for more than 3 weeks
6. Able to speak and understand English without assistance
7. Available to attend an exercise class in Aberdeen for 12 weeks

Exclusion Criteria

1. Secondary or atypical Parkinsonism
2. Severe, unpredictable episodes of motor fluctuation
3. Use of medications known to interfere with cognitive function
4. History of neurological diseases other than PD
5. Any unstable mental or physical condition that prevent consenting and participating in the exercise intervention
6. Unstable or uncontrolled medical conditions

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Feasibility and acceptability assessed via semi-structured interviews at 30 weeks
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath